Acorda Therapeutics

ACOR

Acorda Therapeutics
$13.13 -$0.92 -6.5%
BATS BZX Real Time Price as of March 22, 2019, 4:00 p.m. View Interactive ACOR Charts

A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS.

News & Analysis: Acorda Therapeutics

The Fool has written over 100 articles on Acorda Therapeutics.
All
Market Moves
Earnings










Interactive Chart